Steven Cohen Lexicon Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 584,386 shares of LXRX stock, worth $975,924. This represents 0.0% of its overall portfolio holdings.
Number of Shares
584,386Holding current value
$975,924% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding LXRX
# of Institutions
122Shares Held
159MCall Options Held
2.11MPut Options Held
412K-
Artal Group S.A. Luxembourg, N4118MShares$196 Million15.21% of portfolio
-
Black Rock Inc. New York, NY7.69MShares$12.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.4MShares$10.7 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.92 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA2.39MShares$3.99 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $315M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...